Yingzhi Xu

Also affiliated with Chinese Institute for Brain Research, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Third People's Hospital of Huzhou

Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and PharmaceuticsComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 1 paper. Top paper: “Stroke treatment: Is exosome therapy superior to stem cell therapy?”.

Stroke treatment: Is exosome therapy superior to stem cell therapy?

Biochimie(2020)10.1016/j.biochi.2020.09.025

N/A

0.659DataRank · unranked

80 citations

Wanying Liu, Lu Lian, Yingzhi Xu, Xiaodan Bai, Shixin Xu +2 more